← All Resonate Blends, INC filings

Resonate Blends, INC 10-Q quarterly reports

Quarterly reports, with unaudited financial statements and management’s discussion of the quarter just ended.

OID
KOAN
Resonate Blends, INC
10-Q: Resonate Blends Reports Q1 2025 Results Amidst Significant Business Transformation and Going Concern Doubts
Resonate Blends, Inc. (KOAN) reported a reduced net loss for Q1 2025, driven by increased sales from its new biowellness assets, but continues to face substantial doubt about its ability to continue as a going concern due to a large accumulated deficit and reliance on dilutive financing.
OID
KOAN
Resonate Blends, INC
10-Q: Resonate Blends Reports Increased Revenue Following Emergent Health Corp. Acquisition, But Faces Going Concern Challenges
Resonate Blends, Inc. reports a significant increase in revenue for the nine months ended September 30, 2024, primarily due to the acquisition of Emergent Health Corp. assets, but also discloses ongoing concerns about its ability to continue as a going concern.
OID
KOAN
Resonate Blends, INC
10-Q: Resonate Blends Reports Increased Revenue Following Emergent Health Corp. Asset Acquisition in Q2 2024
Resonate Blends, Inc. reports a significant increase in revenue for the six months ended June 30, 2024, primarily due to the acquisition of assets from Emergent Health Corp., but also identifies material weaknesses in internal controls.
OID
KOAN
Resonate Blends, INC
10-Q: Resonate Blends Reports Q1 2024 Results, Reflecting Emergent Health Corp. Acquisition and Increased Net Loss
Resonate Blends' Q1 2024 results show increased revenue due to the Emergent Health Corp. acquisition, but also a significant net loss increase.